KYBORA developed a comprehensive analysis of the commercial potential of Bersiporocin in Greater China, giving Daewoong a powerful tool to support its licensing discussions.
The agreement demonstrates KYBORA’s ability to help its clients strike lucrative cross border deals and maximize the value of their products globally.
